SecBot SecBot
144 ·Filed Sep 3, 2026

TXG

10x Genomics, Inc.
BEARISH
Impact 4/10
Horizondays Processed2mo ago SEC0001957799-26-000170
Actionable Insight ▼ Bearish

The director's repeated selling pattern (20k shares in August, another 20k proposed now) suggests ongoing monetization, though the dollar amount is small relative to market cap. Monitor for additional Form 144 filings from other insiders and watch for any upcoming earnings or material events that could accelerate selling. The elevated 30-day insider selling activity warrants caution.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$63.22
T+0 close · Sep 3, 2026 · via day close
Latest settled
+47.90%
T+20 · $93.50 · next T+60 in 14d
Vs SPY
+49.08%
α at T+20
Latest observation
+6.54%
T+49 · FF3 residual α
  1. T+0 · Sep 3 $63.22entry
  2. T+1 · 2mo ago −0.90%α −0.52% · $62.65
  3. T+5 · 2mo ago +8.49%α +9.64% · $68.59
  4. T+20 · 6w ago +47.90%α +49.08% · $93.50
  5. T+51 · todayOpen
  6. T+60 · in 14d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director John R. Stuelpnagel filed a Form 144 notice of intent to sell 20,000 shares of Class A common stock, with an estimated aggregate market value of approximately $1.24 million based on a recent sale price of ~$61.75. The shares were originally granted as founder shares in 2017. This is a relatively small sale relative to the company's $8.0B market cap, but it follows a recent sale of the same number of shares on August 11, 2026, and comes amid elevated insider selling activity (9 sales totaling $4.1M in the past 30 days). The filing signals ongoing insider monetization, though the director's role and modest proportional size limit the bearish signal.

Key Facts

  • Director John R. Stuelpnagel filed Form 144 to sell 20,000 shares of Class A common stock.
  • Estimated aggregate market value of the proposed sale is approximately $1,235,045.87.
  • Shares were originally granted as founder shares on August 21, 2017.
  • A prior sale of 20,000 shares occurred on August 11, 2026, for ~$1,155,032.36.
  • Insider selling activity in the past 30 days totals 9 sales worth $4.1M.

Financial Impact

Proposed sale of 20,000 shares valued at ~$1.24M, representing a small fraction of the $8.0B market cap.

dilutioninsider selling

Risk Factors

  • Additional insider selling could pressure the stock.
  • The sale may signal a lack of confidence in near-term prospects, though the director role and small size limit the signal.

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
45% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (TXG), Batch item 10001957799-26-000170
Document: 0001957799-26-000170-index.html0001957799-26-000170
Document: 0001957799-26-000170.txt0001957799-26-000170
144 Filing (TXG), Batch item 40001957799-26-000170
Document: 0001957799-26-000170-index.html0001957799-26-000170
Document: 0001957799-26-000170.txt0001957799-26-000170

Track record

28 reports on TXG

Performance horizon

1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 1 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
  2. Nov 6, 20269d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
  3. Nov 6, 20269d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
  4. Nov 5, 202610d ago 8-K Bullish 6/10 No price data
  5. Nov 5, 202610d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
  6. Nov 2, 202613d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
  7. Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
  8. Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
  9. Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
  10. Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
Showing 10 of 28

US Market Status

Market Closed · Opens Tue (17h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 3, 2026